人工智能在中药开发中的应用

IF 2.7 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Xuebing He, Mingna Sun, Tungalag Battulga, Brent R. Copp, Dilobarkhon Kodirova Rustamovna, Hongyan Li, Sagdullaev Shamansur Shahsaidovich, Janar Jenis, Yuqing Wang, Lu Liang, Jianye Zhang
{"title":"人工智能在中药开发中的应用","authors":"Xuebing He,&nbsp;Mingna Sun,&nbsp;Tungalag Battulga,&nbsp;Brent R. Copp,&nbsp;Dilobarkhon Kodirova Rustamovna,&nbsp;Hongyan Li,&nbsp;Sagdullaev Shamansur Shahsaidovich,&nbsp;Janar Jenis,&nbsp;Yuqing Wang,&nbsp;Lu Liang,&nbsp;Jianye Zhang","doi":"10.1111/bcpt.70066","DOIUrl":null,"url":null,"abstract":"<p>Traditional Chinese medicine (TCM) has long been recognized for its mild therapeutic effects, significant efficacy and minimal adverse reactions. However, challenges such as reliance on human expertise in TCM production and quality control, unclear compositions and usage of TCM and ambiguous targets hinder its sustainable development. The emergence of artificial intelligence (AI) provides transformative potential for addressing these limitations. Recent studies have demonstrated that AI promotes the intelligent industrialization of TCM, ensures effective TCM quality, assists in the discovery of TCM targets and recommends scientifically formulated TCM prescriptions. This review consolidates and evaluates recent progress in applying AI to TCM, with a focus on pharmaceutical development, quality control and research innovation. By providing a detailed and systematic overview, this review aims to highlight the role of AI in advancing the scientific and sustainable evolution of TCM.</p>","PeriodicalId":8733,"journal":{"name":"Basic & Clinical Pharmacology & Toxicology","volume":"137 1","pages":""},"PeriodicalIF":2.7000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bcpt.70066","citationCount":"0","resultStr":"{\"title\":\"Application of Artificial Intelligence in the Development of Traditional Chinese Medicine\",\"authors\":\"Xuebing He,&nbsp;Mingna Sun,&nbsp;Tungalag Battulga,&nbsp;Brent R. Copp,&nbsp;Dilobarkhon Kodirova Rustamovna,&nbsp;Hongyan Li,&nbsp;Sagdullaev Shamansur Shahsaidovich,&nbsp;Janar Jenis,&nbsp;Yuqing Wang,&nbsp;Lu Liang,&nbsp;Jianye Zhang\",\"doi\":\"10.1111/bcpt.70066\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Traditional Chinese medicine (TCM) has long been recognized for its mild therapeutic effects, significant efficacy and minimal adverse reactions. However, challenges such as reliance on human expertise in TCM production and quality control, unclear compositions and usage of TCM and ambiguous targets hinder its sustainable development. The emergence of artificial intelligence (AI) provides transformative potential for addressing these limitations. Recent studies have demonstrated that AI promotes the intelligent industrialization of TCM, ensures effective TCM quality, assists in the discovery of TCM targets and recommends scientifically formulated TCM prescriptions. This review consolidates and evaluates recent progress in applying AI to TCM, with a focus on pharmaceutical development, quality control and research innovation. By providing a detailed and systematic overview, this review aims to highlight the role of AI in advancing the scientific and sustainable evolution of TCM.</p>\",\"PeriodicalId\":8733,\"journal\":{\"name\":\"Basic & Clinical Pharmacology & Toxicology\",\"volume\":\"137 1\",\"pages\":\"\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2025-06-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bcpt.70066\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Basic & Clinical Pharmacology & Toxicology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/bcpt.70066\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Basic & Clinical Pharmacology & Toxicology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bcpt.70066","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

中药以其疗效轻、疗效显著、不良反应小而著称。然而,中药生产和质量控制依赖人类专业知识、中药成分和用法不明确以及目标不明确等挑战阻碍了其可持续发展。人工智能(AI)的出现为解决这些限制提供了变革性的潜力。近年来的研究表明,人工智能促进了中药的智能产业化,保证了中药的有效质量,帮助发现中药靶点,推荐科学配方的中药方剂。本综述总结和评价了人工智能在中药领域应用的最新进展,重点是药物开发、质量控制和研究创新。通过提供详细和系统的概述,本文旨在强调人工智能在促进中医科学和可持续发展中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Application of Artificial Intelligence in the Development of Traditional Chinese Medicine

Traditional Chinese medicine (TCM) has long been recognized for its mild therapeutic effects, significant efficacy and minimal adverse reactions. However, challenges such as reliance on human expertise in TCM production and quality control, unclear compositions and usage of TCM and ambiguous targets hinder its sustainable development. The emergence of artificial intelligence (AI) provides transformative potential for addressing these limitations. Recent studies have demonstrated that AI promotes the intelligent industrialization of TCM, ensures effective TCM quality, assists in the discovery of TCM targets and recommends scientifically formulated TCM prescriptions. This review consolidates and evaluates recent progress in applying AI to TCM, with a focus on pharmaceutical development, quality control and research innovation. By providing a detailed and systematic overview, this review aims to highlight the role of AI in advancing the scientific and sustainable evolution of TCM.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.60
自引率
6.50%
发文量
126
审稿时长
1 months
期刊介绍: Basic & Clinical Pharmacology and Toxicology is an independent journal, publishing original scientific research in all fields of toxicology, basic and clinical pharmacology. This includes experimental animal pharmacology and toxicology and molecular (-genetic), biochemical and cellular pharmacology and toxicology. It also includes all aspects of clinical pharmacology: pharmacokinetics, pharmacodynamics, therapeutic drug monitoring, drug/drug interactions, pharmacogenetics/-genomics, pharmacoepidemiology, pharmacovigilance, pharmacoeconomics, randomized controlled clinical trials and rational pharmacotherapy. For all compounds used in the studies, the chemical constitution and composition should be known, also for natural compounds.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信